- Home
- CBAN vs ETON Comparison
CBAN vs ETON Comparison
Compare CBAN & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBAN | ETON |
|---|---|---|
| Founded | 1975 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 436.3M | 411.9M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CBAN | ETON |
|---|---|---|
| Price | $19.70 | $17.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $31.00 |
| AVG Volume (30 Days) | 166.7K | ★ 298.2K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | ★ 9.68 | N/A |
| EPS | ★ 1.17 | N/A |
| Revenue | N/A | ★ $39,011,000.00 |
| Revenue This Year | $35.41 | $107.23 |
| Revenue Next Year | $4.84 | $29.72 |
| P/E Ratio | $16.87 | ★ N/A |
| Revenue Growth | N/A | ★ 23.29 |
| 52 Week Low | $13.99 | $11.09 |
| 52 Week High | $21.46 | $23.00 |
Technical Indicators
Market Signals| Indicator | CBAN | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | 54.77 |
| Support Level | $15.96 | $16.04 |
| Resistance Level | $21.25 | $17.59 |
| Average True Range (ATR) | 0.60 | 1.03 |
| MACD | -0.13 | -0.10 |
| Stochastic Oscillator | 32.45 | 27.50 |
Price Performance
Historical ComparisonAbout CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.